trastuzumab-dkst
CHEBI:CHEBI_747185
Drug Classification
-
chemical entityView Class →
CHEBI:24431
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- rxcui
- 2179763
- dosage_form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- product_type
- HUMAN PRESCRIPTION DRUG
- listing_expiration_date
- 20251231
- route
- INTRAVENOUS
- marketing_category
- BLA
- marketing_start_date
- 20231001
- package_marketing_start_date
- 20231001
- nui
- N0000020008
- pharm_class_epc
- HER2/neu Receptor Antagonist [EPC]
- pharm_class
- HER2/Neu/cerbB2 Antagonists [MoA]
- pharm_class_moa
- HER2/Neu/cerbB2 Antagonists [MoA]
- generic_name
- trastuzumab-dkst
- brand_name
- OGIVRI
- brand_name_base
- OGIVRI
- product_ndc
- 83257-003
- application_number
- BLA761074
- labeler_name
- Biocon Biologics Inc.
- manufacturer_name
- Biocon Biologics Inc.
- spl_id
- d97f37b0-df01-f450-7ff4-419b33b4ec89
- package_ndc
- 83257-001-11
- package_description
- 1 VIAL in 1 CARTON (83257-001-11) / 15 mL in 1 VIAL
- unii
- P188ANX8CK
- spl_set_id
- b6465b44-a6dd-f99c-d009-6851cf05169c
- active_ingredient_name
- TRASTUZUMAB
- active_ingredient_strength
- 150 mg/7.4mL
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class